Development
PROCEPT BioRobotics Corporation
PRCT
$62.91
-$2.14-3.29%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -105.90M | -106.57M | -104.56M | -98.45M | -87.15M |
| Total Depreciation and Amortization | 3.81M | 3.15M | 2.80M | 2.88M | 2.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.25M | 22.47M | 20.92M | 18.40M | 15.42M |
| Change in Net Operating Assets | -26.16M | -27.44M | -28.46M | -20.90M | -11.49M |
| Cash from Operations | -108.00M | -108.38M | -109.29M | -98.08M | -80.38M |
| Capital Expenditure | -25.21M | -17.36M | -13.09M | -7.94M | -2.65M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25.21M | -17.36M | -13.09M | -7.94M | -2.65M |
| Total Debt Issued | -- | 51.20M | 51.20M | 51.20M | 51.20M |
| Total Debt Repaid | -- | -50.00M | -50.00M | -50.00M | -50.00M |
| Issuance of Common Stock | 167.80M | 166.42M | 5.07M | 5.51M | 6.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -4.00M | -4.00M | -4.00M | -4.00M |
| Cash from Financing | 167.80M | 163.61M | 2.27M | 2.70M | 3.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.59M | 37.87M | -120.11M | -103.32M | -79.42M |